Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Minsu Ock, Ji Soo Shin & Seung Won Ra. (2022) Safety and Effectiveness of Varenicline in Korean Smokers: A Nationwide Post-Marketing Surveillance Study. Patient Preference and Adherence 16, pages 413-426.
Read now
Read now
Jason L. Niehaus, Nelson D. Cruz-Bermúdez & Julie A. Kauer. (2009) Plasticity of Addiction: A Mesolimbic Dopamine Short-Circuit?. American Journal on Addictions 18:4, pages 259-271.
Read now
Read now
Articles from other publishers (42)
Lavanya C, Pooja S, Abhay H Kashyap, Abdur Rahaman, Swarna Niranjan & Vidya Niranjan. (2023) Novel Biomarker Prediction for Lung Cancer Using Random Forest Classifiers. Cancer Informatics 22, pages 117693512311679.
Crossref
Crossref
Luciane Cruz Lopes, Yuan Zhang, Stephanie Ross, Izabela FuloneMeng Zhu, Kelly K. O’BrienSureka PavalagantharajahFrank T. LeoneDavid P. L. SachsHasmeena Kathuria, Rachael L. Murray & Yu-Qing Zhang. (2022) Varenicline for Tobacco-Dependent Adults Who Are Not Ready to Discontinue Use: A Systematic Review and Meta-Analysis. Annals of the American Thoracic Society 19:12, pages 2077-2086.
Crossref
Crossref
Yajnaseni Chakraborti, Donna L Coffman & Megan E Piper. (2022) Time-Varying Mediation of Pharmacological Smoking Cessation Treatments on Smoking Lapse via Craving, Cessation Fatigue, and Negative Mood. Nicotine & Tobacco Research 24:10, pages 1548-1555.
Crossref
Crossref
Marcela C. Smid & Mishka Terplan. (2022) What Obstetrician–Gynecologists Should Know About Substance Use Disorders in the Perinatal Period. Obstetrics & Gynecology 139:2, pages 317-337.
Crossref
Crossref
Mina Fukuda. (2021) Nicotine-free electronic-cigarettes for smoking cessation: Occasional reinforcement during extinction. Learning and Motivation 76, pages 101766.
Crossref
Crossref
Stefan C. STANEL & Pilar RIVERA-ORTEGA. (2021) Smoking cessation: strategies and effects in primary and secondary cardiovascular prevention. Panminerva Medica 63:2.
Crossref
Crossref
M. Adrienne McGinn, Caroline B. Pantazis, Brendan J. Tunstall, Renata C.N. Marchette, Erika R. Carlson, Nadia Said, George F. Koob & Leandro F. Vendruscolo. 2021. Neurobiology of Addiction and Co-Morbid Disorders. Neurobiology of Addiction and Co-Morbid Disorders
409
472
.
Devyn Oliver & Michael M Francis. 2001. eLS. eLS
205
213
.
Jean Wong, Dong An, Richard D. Urman, David O. Warner, Hanne Tønnesen, Raviraj Raveendran, Hairil R. Abdullah, Kurt Pfeifer, John Maa, Barry Finegan, Emily Li, Ashley Webb, Angela F. Edwards, Paul Preston, Nathalie Bentov, Deborah C. Richman & Frances Chung. (2019) Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement on Perioperative Smoking Cessation. Anesthesia & Analgesia 131:3, pages 955-968.
Crossref
Crossref
Farzad Masoudkabir, Negin Yavari, Mina Pashang, Saeed Sadeghian, Arash Jalali, Abbasali Karimi, Jamshid Bagheri, Kiomars Abbasi, Saeed Davoodi, Abbas Salehi Omran, Mahmood Shirzad & Seyed Hossein Ahmadi Tafti. (2020) Smoking Cessation After Surgery and Midterm Outcomes of Surgical Revascularization. The Annals of Thoracic Surgery 109:6, pages 1874-1879.
Crossref
Crossref
Ann Marie Centner, Pradeep G. Bhide & Gloria Salazar. (2020) Nicotine in Senescence and Atherosclerosis. Cells 9:4, pages 1035.
Crossref
Crossref
Dong An & Jean Wong. (2020) Improving Surgical Outcomes and Patient Health: Perioperative Smoking Cessation Interventions. Current Anesthesiology Reports 10:1, pages 12-18.
Crossref
Crossref
Nidhi Singh & Jaya Pandey. (2020) One-Pot, Water-Mediated, H2O2-HCl Catalyzed Synthesis of Benzazepines. Asian Journal of Chemistry 32:5, pages 1165-1168.
Crossref
Crossref
Amol V. Shivange, Philip M. Borden, Anand K. Muthusamy, Aaron L. Nichols, Kallol Bera, Huan Bao, Ishak Bishara, Janice Jeon, Matthew J. Mulcahy, Bruce Cohen, Saidhbhe L. O'Riordan, Charlene Kim, Dennis A. Dougherty, Edwin R. Chapman, Jonathan S. Marvin, Loren L. Looger & Henry A. Lester. (2019) Determining the pharmacokinetics of nicotinic drugs in the endoplasmic reticulum using biosensors. Journal of General Physiology 151:6, pages 738-757.
Crossref
Crossref
Marc L. Steinberg, Shou-En Lu & Jill M. Williams. (2018) Varenicline for smoking reduction in smokers not yet ready to quit: A double-blind, proof-of-concept randomized clinical trial. Addictive Behaviors 84, pages 20-26.
Crossref
Crossref
Karen J. Derefinko, Francisco I. Salgado García & Daniel D. Sumrok. (2018) Smoking Cessation for Those Pursuing Recovery from Substance Use Disorders. Medical Clinics of North America 102:4, pages 781-796.
Crossref
Crossref
Yener Unhelkar, Karen Murrell & Christopher Bryant. 2017. Big Book of Emergency Department Psychiatry. Big Book of Emergency Department Psychiatry
199
234
.
Catherine J. Lucas, Joanne Patel & Jennifer H. Martin. (2017) Predicting drug interactions in addiction treatment. Internal Medicine Journal 47:8, pages 872-878.
Crossref
Crossref
Tianjiao Dai & Sanjay Shete. (2016) Time-varying SMART design and data analysis methods for evaluating adaptive intervention effects. BMC Medical Research Methodology 16:1.
Crossref
Crossref
Natalia Obsada & Jadwiga Zalewska-Kaszubska. (2016) Wareniklina – częściowy agonista receptorów nikotynowych w terapii zespołu uzależnienia od alkoholu. Alcoholism and Drug Addiction 29:2, pages 93-101.
Crossref
Crossref
Myrto Ashe. 2015. Integrative Therapies for Depression. Integrative Therapies for Depression
251
262
.
Kenneth L. Smith, Tom A. Hummer & Leslie A. Hulvershorn. (2015) Pathological Video Gaming and Its Relationship to Substance Use Disorders. Current Addiction Reports 2:4, pages 302-309.
Crossref
Crossref
Kerry L. Price, Reidun K. Lillestol, Chris Ulens & Sarah C.R. Lummis. (2015)
Varenicline Interactions at the 5-HT
3
Receptor Ligand Binding Site are Revealed by 5-HTBP
. ACS Chemical Neuroscience 6:7, pages 1151-1157.
Crossref
Crossref
Shade A. Agboola, Tim Coleman, Ann McNeill & Jo Leonardi-Bee. (2015) Abstinence and relapse among smokers who use varenicline in a quit attempt-a pooled analysis of randomized controlled trials. Addiction 110:7, pages 1182-1193.
Crossref
Crossref
Karen J. Hartwell, Kathleen T. Brady & Mark S. George. 2015. The Wiley Handbook on the Cognitive Neuroscience of Addiction. The Wiley Handbook on the Cognitive Neuroscience of Addiction
390
404
.
Darlene H. Brunzell, Alexandra M. Stafford & Claire I. Dixon. (2015) Nicotinic Receptor Contributions to Smoking: Insights from Human Studies and Animal Models. Current Addiction Reports 2:1, pages 33-46.
Crossref
Crossref
Christopher Bullen. (2014) Electronic Cigarettes for Smoking Cessation. Current Cardiology Reports 16:11.
Crossref
Crossref
Yohalakshmi Chelladurai & Sonal Singh. (2014) Varenicline and cardiovascular adverse events: a perspective review. Therapeutic Advances in Drug Safety 5:4, pages 167-172.
Crossref
Crossref
Melanie Canterberry, Colleen A. Hanlon, Karen J. Hartwell, Xingbao Li, Max Owens, Todd LeMatty, James J. Prisciandaro, Jeffrey Borckardt, Michael E. Saladin, Kathleen T. Brady & Mark S. George. (2013) Sustained Reduction of Nicotine Craving With Real-Time Neurofeedback: Exploring the Role of Severity of Dependence. Nicotine & Tobacco Research 15:12, pages 2120-2124.
Crossref
Crossref
Sabina H.L. de Villiers, Katherine E. Cornish, Andrew J. Troska, Marco Pravetoni & Paul R. Pentel. (2013) Increased efficacy of a trivalent nicotine vaccine compared to a dose-matched monovalent vaccine when formulated with alum. Vaccine 31:52, pages 6185-6193.
Crossref
Crossref
Lara A. Ray, Katy Lunny, Spencer Bujarski, Nathasha Moallem, Jennifer L. Krull & Karen Miotto. (2013) The effects of varenicline on stress-induced and cue-induced craving for cigarettes. Drug and Alcohol Dependence 131:1-2, pages 136-142.
Crossref
Crossref
Kate M. Hathaway & Yvette Erasmus. 2012. Integrative Therapies in Lung Health and Sleep. Integrative Therapies in Lung Health and Sleep
223
246
.
Jill S. Rumberger & Christopher S. Hollenbeak. (2012) Potential Costs and Benefits of Statewide Smoking Cessation in Pennsylvania. Journal of Smoking Cessation 6:1, pages 25-32.
Crossref
Crossref
Neil E. Paterson. (2011) Translational research in addiction: Toward a framework for the development of novel therapeutics. Biochemical Pharmacology 81:12, pages 1388-1407.
Crossref
Crossref
John A. Stapleton & Gay Sutherland. (2011) Treating heavy smokers in primary care with the nicotine nasal spray: randomized placebo-controlled trial. Addiction 106:4, pages 824-832.
Crossref
Crossref
Laura MattioliMarina Perfumi. (2009)
Evaluation of
Rhodiola rosea
L. extract on affective and physical signs of nicotine withdrawal in mice
. Journal of Psychopharmacology 25:3, pages 402-410.
Crossref
Crossref
Hélène M. Faessel, R. Scott Obach, Hans Rollema, Patanjali Ravva, Kathryn E. Williams & Aaron H. Burstein. (2010) A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Varenicline for Smoking Cessation. Clinical Pharmacokinetics 49:12, pages 799-816.
Crossref
Crossref
Jill S. Rumberger & Christopher S. Hollenbeak. (2012) Potential Costs and Benefits of Statewide Smoking Cessation in Pennsylvania. Journal of Smoking Cessation 5:2, pages 136-144.
Crossref
Crossref
Sabina H.L. de Villiers, Nina Lindblom, Genadiy Kalayanov, Sandra Gordon, Ivan Baraznenok, Anna Malmerfelt, Monica M. Marcus, Anette M. Johansson & Torgny H. Svensson. (2010) Nicotine hapten structure, antibody selectivity and effect relationships: Results from a nicotine vaccine screening procedure. Vaccine 28:10, pages 2161-2168.
Crossref
Crossref
Linda P. Dwoskin, Andrew M. Smith, Thomas E. Wooters, Zhenfa Zhang, Peter A. Crooks & Michael T. Bardo. (2009) Nicotinic receptor-based therapeutics and candidates for smoking cessation. Biochemical Pharmacology 78:7, pages 732-743.
Crossref
Crossref
Beth Bock, Beth Lewis, Ernestine Jennings, Joshua Marcus-Blank & Bess H. Marcus. (2009) Women and smoking cessation: Challenges and opportunities. Current Cardiovascular Risk Reports 3:3, pages 205-210.
Crossref
Crossref
Andrew Pipe. (2008) Smoking cessation: primacy in cardiovascular disease prevention. Current Opinion in Cardiology 23:5, pages 462-464.
Crossref
Crossref